X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/xcopri-cenobamate-tablets-cv-receives-fda-approval-for-alternate-methods-of-administration-that-include-crushed-tablet-in-liquid-suspension-taken-orally-or-through-a-nasogastric-tube-302113538.html
https://www.prnewswire.com/news-releases/sk-life-science-announces-data-presentations-for-xcopri-cenobamate-tablets-cv-at-the-2024-american-academy-of-neurology-annual-meeting-302110843.html
https://www.fiercepharma.com/marketing/sk-life-science-marks-purple-day-epilepsy-awareness-highlighting-patient-support-programs
https://www.prnewswire.com/news-releases/sk-life-science-publishes-updated-real-world-experience-on-cenobamate-in-epilepsia-based-on-recent-100-000-patient-exposure-milestone-302087218.html
https://www.prnewswire.com/news-releases/sk-life-science-to-host-symposium-and-present-new-data-at-the-american-epilepsy-society-aes-2023-annual-meeting-301998374.html
https://endpts.com/sk-life-science-sets-up-an-indoor-rainstorm-to-point-to-its-anti-seizure-drug-xcopris-full-coverage/
https://www.prnewswire.com/news-releases/latest-xcopri-cenobamate-tablets-cv-post-hoc-analysis-presented-at-the-75th-american-academy-of-neurology-annual-meeting-301798363.html
https://www.prnewswire.com/news-releases/sk-life-science-presents-latest-data-on-xcopri-cenobamate-tablets-cv-in-adults-with-partial-onset-focal-seizures-at-the-aes-2022-annual-meeting-301690317.html
https://www.prnewswire.com/news-releases/sk-life-science-to-present-latest-xcopri-cenobamate-tablets-cv-data-at-the-american-epilepsy-society-2022-annual-meeting-301685636.html
https://www.prnewswire.com/news-releases/long-term-efficacy-and-safety-data-of-xcopri-cenobamate-tablets-cv-published-in-neurology-301572544.html
Market Place
Share 
